Search

everythinglearnresearchcommunity

for

Search:↓

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Gut bacteria affect female reproductive health and may help diagnose and treat related diseases.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

PCOS is a common hormonal disorder in women linked to several health risks and can be managed through various treatments.

m6A deregulation plays a key role in PCOS and could lead to new treatments.

Letrozole is better for single follicle development and endometrial thickness in PCOS, with no significant difference in pregnancy rates compared to clomiphene.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Neogynon effectively prevents pregnancy but may cause side effects like headaches and menstrual changes.

A new method effectively predicts estrogen-related health effects for early screening.

Nanotechnology improves Clomiphene citrate's effectiveness and reduces side effects for treating ovulatory disorders.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

Different types of PCOS need specific diagnosis methods and treatments.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

A mix of Polygonatum sibiricum and Nelumbinis semen may ease menopause symptoms with fewer side effects.

Women with irregular periods should be checked for PCOS and treated early to prevent complications, with birth control pills helping to manage symptoms.

The May issue discussed publishing agreements and four studies on cholesterol in hair, cancer cell changes, hormones in the uterus, and skin protein effects.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.